ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $19,800,000 | +65.1% | 705,608 | +100.0% | 0.15% | -12.1% |
Q3 2021 | $11,992,000 | -58.4% | 352,804 | -50.0% | 0.17% | -7.0% |
Q2 2021 | $28,832,000 | +103.0% | 705,608 | +100.0% | 0.19% | +3.9% |
Q1 2021 | $14,204,000 | -73.5% | 352,804 | -61.0% | 0.18% | -68.6% |
Q4 2020 | $53,504,000 | +32.6% | 904,854 | +9.0% | 0.57% | -2.5% |
Q3 2020 | $40,363,000 | +73.8% | 830,000 | +72.9% | 0.59% | +56.6% |
Q2 2020 | $23,222,000 | +73.0% | 480,000 | -3.0% | 0.38% | +7.4% |
Q1 2020 | $13,424,000 | +47.1% | 495,000 | +62.3% | 0.35% | +93.4% |
Q4 2019 | $9,126,000 | +0.1% | 305,000 | +3.4% | 0.18% | -26.4% |
Q3 2019 | $9,116,000 | -33.8% | 295,000 | +3.5% | 0.25% | -22.2% |
Q2 2019 | $13,766,000 | – | 285,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |